Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories
Deals
Features
News
Region
Sectors
Size

Page 2

Bibit.id brings in $65m
Harvard University’s endowment has participated in a funding round for the robo-advisory platform.
Kuur inks $185m acquisition
Athenex will pay $70m upfront and up to $115m in milestone payments to acquire Kuur Therapeutics, providing exits to Baylor College and IP Group.
Inivata inspires $390m acquisition
NeoGenomics has exercised its option to buy Inivata, a precision cancer diagnostics company that was formed to exploit Cambridge and CRUK research seven years ago.
Oxford Nanopore orchestrates $270m round
Oxford Nanopore, the UK-based DNA sequencing technology spinout of University of Oxford, pocketed £195m ($270m) in equity financing today from investors including commercialisation firm IP Group. Imaging technology producer Nikon, Temasek, Wellington Management and M&G Investment took part in the round, providing $174m, while unnamed, existing backers also contributed capital. IP Group committed £26m, its […]
Daily deal net: April 30, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Vaccitech injects shares into public market
Vaccitech, which developed the technology underlying Oxford’s covid vaccine, has priced its shares and will raise more than $110m in its IPO.
Adcendo accepts series A funding
Novo Seeds co-led a $61.7m round for the oncology therapy developer to help commercialise research originating at University of Copenhagen and Rigshospitalet.
Alchemy turns interest into $80m
Stanford University returned for the cryptocurrency exchange infrastructure developer's series B round.
Exscientia erects $225m series D
Less than two months after closing a $100m series C round, the Durham spinout has raised $225m in a series D led by SoftBank Vision Fund 2.
Vera Therapeutics vies for public markets spot
Yale’s immunological and inflammatory disease therapy developer has filed for an offering with an $86.3m placeholder target.

test reg

Login